Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
Rivus Pharmaceuticals has raised $57.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.
Rivus Pharmaceuticals's investors include RA Capital Management, Bain Capital Life Sciences, Longitude Capital, Medicxi, BB Biotech Ventures.
Rivus Pharmaceuticals is headquartered in Charlottesville, United States.
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
Rivus Pharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rivus Pharmaceuticals — Funding & Investors." VCBacked, January 16, 2025, https://www.vcbacked.co/company/rivus-pharmaceuticals. Accessed November 12, 2026.
VCBacked. (2025). Rivus Pharmaceuticals — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/rivus-pharmaceuticals
{{cite web |title=Rivus Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/rivus-pharmaceuticals |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Rivus Pharmaceuticals? Request a listing update